API | oxazolidine

oxazolidine Report issue

Small molecule Experimental

Active Ingredient History

NOW

Oxazolidine is a five-membered heterocycle ringwith the formula (CH2)3(NH)O.The O atom and NH groups are not mutually bonded, in contrast to isoxazolidine. Oxazolidines are derivatives of the parent oxazolidine owing to the presence of substituents on carbon and/or nitrogen. Oxazolines are unsaturated analogues of oxazolidines. ^Wikipedia

Chemistry

SMILES: C1COCN1
InChIKey: WYNCHZVNFNFDNH-UHFFFAOYSA-N
Mol. Mass: 73.09
ALogP: -0.44 Partition coefficient
ChEMBL Molecule:
oxazolidine

More Chemistry

Pharmacology

Mechanism of Action:
- 50S ribosomal protein L2 (Escherichia coli K-12) ^UniProt
Multi-specific: Missing data
Black Box: No
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: No

Organizations (1)

Research & Development (1)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (1)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (1)

Neoplasms (Phase 2)

Overview

Highest Phase: Phase 2
# of Trials: 1
# of Trial Organizations: 1

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue